A Viral Platform for Chemical Modification and Multivalent Display
© Peabody; licensee BioMed Central Ltd. 2003
Received: 27 May 2003
Accepted: 15 July 2003
Published: 15 July 2003
The ability to chemically modify the surfaces of viruses and virus-like particles makes it possible to confer properties that make them potentially useful in biotechnology, nanotechnology and molecular electronics applications. RNA phages (e.g. MS2) have characteristics that make them suitable scaffolds to which a variety of substances could be chemically attached in definite geometric patterns. To provide for specific chemical modification of MS2's outer surface, cysteine residues were substituted for several amino acids present on the surface of the wild-type virus particle. Some substitutions resulted in coat protein folding or stability defects, but one allowed the production of an otherwise normal virus-like particle with an accessible sulfhydryl on its surface.
The ability of viruses to self-assemble into nanoscale particles of discrete size and definite geometry gives them potential utility in a variety of nano- and biotechnology applications. Efforts to adapt icosahedral virus particles for use as templates for materials synthesis, as platforms for the multivalent presentation of ligands, and even as possible molecular electronic components have been described recently [1–7]. Work reported to date has made use of Cowpea Chlorotic Mottle Virus [1–4] and Cowpea Mosaic Virus [5–7]. Experiments that explore the utility of the RNA bacteriophage MS2 for similar purposes are presented here.
RNA bacteriophages represent attractive systems for engineering new properties into viruses and virus-like particles. Each RNA phage particle is comprised of 180 copies of a single coat protein polypeptide about 130 amino acids in length, one copy of the maturase protein, and one molecule of viral genome RNA. The coat protein itself possesses all the information needed for assembly into an icosahedron with a diameter of about 25 nm. This means that virus capsids can be produced by expression of the coat gene from a plasmid in E. coli without the need for other viral components. The coat protein dimer, the structural unit from which capsids are assembled, possesses a high-affinity binding site for a specific RNA hairpin. Since this hairpin can function as a packaging signal, it is straight-forward to engineer the encapsidation of an arbitrarily chosen RNA by fusing it to this so-called pac site and expressing it in an E. coli strain that also produces coat protein .
RNA phage coat proteins are amenable to facile genetic manipulation. It is, of course, a simple matter to introduce any desired amino acid substitution by site-directed mutagenesis of the coat protein cDNA clone, but systems also exist that facilitate random mutagenesis and selection of coat mutants having altered RNA binding  and particle assembly  properties. A simple assay for correct particle assembly  makes it easy to screen out those mutants that acquire undesired defects in protein folding or assembly. Moreover, because coat proteins produced from a plasmid in E. coli are fully competent for particle assembly, changes in coat protein structure that are incompatible with the normal virus life cycle can be easily introduced and propagated. This is an advantage not readily available in some other systems. Moreover, cDNA clones of viral RNA are infectious, making it easy to produce viable recombinant viruses that incorporate any mutation that does not interfere with virus viability. Both virus and virus-like particles are readily produced in large quantities and high purity.
High resolution x-ray structures are available for a number of RNA phages, including MS2 [12–18], so that desirable sites for modification can be identified easily. Here I describe the production of a bacteriophage MS2 coat protein mutant that displays a reactive thiol on the surface of the virus-like particle. Thiols are among the most useful functional groups found in proteins. It can bind a variety of metals and reacts with a large collection of organic reagents, thus making cysteines obvious targets for protein modification reactions. Wild-type MS2 coat protein contains two cysteines, but they are sequestered in the interior of the protein where they should be relatively unreactive. The introduction of an accessible cysteine on the surface of the MS2 capsid therefore should create the opportunity for multivalent display of a large number of different potential ligands on its surface.
Introduction of surface cysteines and their effects on coat protein structure
In past work it has frequently been possible to suppress the effects of mutations on MS2 coat protein folding/stability by incorporating them into so-called single-chain dimers. Because of the proximity of the N-terminus of one subunit of the coat protein dimer to the C-terminus of the other subunit, it is possible to genetically fuse them into a single polypeptide chain. Covalently linking the two monomers in this manner makes the dimer relatively resistant to the destabilizing effects of many amino acid substitutions and even of peptide insertions [20–23]. In an effort to revert their effects on coat protein structure, the G13C, G14C, D114C and G115C mutations were incorporated into single-chain dimer constructs. However, in none of these cases was the ability to produce active coat protein restored (results not shown).
Accessibility and reactivity of the new cysteine
Single amino acid substitutions frequently have global effects on protein folding and stability. Considering their locations in the coat protein structure it is not surprising that some substitutions of AB loop residues disrupted folding. The loop makes a tight turn and the glycines present at positions 13 and 14 are probably needed to prevent the crowding that results when amino acids with bulkier side chains are introduced here. Moreover, the defects caused by the G13C and G14C substitutions must be fairly severe, since they are not reverted by their incorporation into single-chain coat protein dimers. Genetic fusion of the subunits of the dimer was shown previously to revert the destabilizing effects of variety of mutations, including a wide range of amino acid substitutions at different locations on the β-sheet [21, 22], temperature-sensitive mutations occurring at numerous sites through-out the structure (unpublished observations), and even insertions into the AB-loop sequence itself . The T15C mutation, on the other hand is tolerated structurally. Cysteine is a slightly smaller amino acid than the threonine it replaces and so would not be expected to introduce stereochemical difficulties of the sort that likely explain the G13C and G14C defects.
It is less obvious why the substitutions at residues aspartic acid114 and glycine115 lead to folding-defects, but these residues also are involved in a turn of the polypeptide, this one connecting the two coat protein alpha-helices. The severity of the defects conferred by the cysteines introduced here is also indicated by the failure to revert them in single-chain dimers.
As these results illustrate, amino acid substitutions can disrupt protein folding and stability with an annoyingly high frequency. It should be noted, though, that at least two different strategies are available for efforts to render the substitutions tolerable. The first is to create single-chain dimers of the mutant proteins [20–23]. Although this was ineffective in the cases of the four defective mutants described here, it has in the past proven an efficient and simple means of reverting coat protein folding defects and will likely be useful for many of the other defects one might encounter. Moreover, since single-chain dimers allow independent control of the amino acid sequences in the two halves of the "dimer", it provides a means to alter by one-half the number of thiols on the virus surface, giving an added level of control over the density of modifiable sites. A second strategy for reversion of folding/stability defects is to isolate mutations at second sites that suppress those defects. A gel diffusion method that allows one to distinguish bacterial colonies that produce soluble, properly assembled coat protein from those that do not has been described elsewhere .
The sites modified in this study were chosen because they are highly exposed on the virus surface, but a number of other sites in coat protein are also located in potentially suitable positions, and some of them are likely to be more tolerant of substitution than those tested so far. The capacity to introduce cysteines at alternative positions would allow one to alter the relative geometric arrangement of reactive sites, an additional parameter that should influence the properties of specific modified virus-like particles. The procedure outlined here serves as a guide to the identification of residues whose substitution is tolerated.
Wild-type MS2 coat protein has two cysteines, one at position 46 and the other at 101. Under the conditions used in this study, no evidence that these cysteines were modified by fluoroscein-5-maleimide was observed. This selectivity is a little surprising in view of the previous demonstrations that cysteine46 is somewhat susceptible to reaction with sulfhydryl-specific reagents [26, 27] even though, like cysteine101, it is relatively buried within the coat protein tertiary structure. However, those prior studies were conducted using isolated coat protein dimers. Here intact virus-like particles were used. They apparently afford greater protection to cysteine46. Alternatively, because it is bulkier than the reagents used in the previous studies (e.g. N-ethylmaleimide), the fluoroscein-5-maleimide reagent might not as easily gain access to cysteine46.
The ability to chemically modify specific sites on virus particle surfaces is a potentially powerful approach to the production of new materials for biotechnology, nanotechnology and molecular electronics. It makes possible the use of the virus-like particle as a scaffold for the attachment of a large variety of substances including metals, organics, peptides, and nucleic acids in a regular geometric array. Thus, one can think of these virus-like particles as self-assembling and highly regular nanospheres, potentially susceptible to a wide range of chemical modifications at specific surface locations. They may be suitable for use in applications currently employing small spheres constructed by other, less controlled means. The ability to specifically encapsidate and protect arbitrarily chosen RNAs within such particles suggests additional applications. Experiments are currently underway to explore some of the possibilities.
Mutations were introduced into the MS2 coat sequence using mismatched oligonucleotide primers (from Integrated DNA Technologies) in a PCR-based overlap extension method [28, 29]. The mutations were constructed using the following codon changes. G13C (GGC to UGC), G14C (GGA to UGU), T15C AGU to UGU), D114C (GAU to UGU) and G115C (GGA to UGU). The resulting PCR products were cloned as Xba I-Bam HI fragments in the T7 expression vector called pET3d  thus creating a series of derivatives of the plasmid called pETCT . The nucleotide sequences of each of the mutant coat genes were determined at the UNM Center for Genetics in Medicine. Coat proteins were produced by over-expression in strain BL21(DE3)/pLysS [10, 19]. The presence of virus-like particles in crude cell lysates was determined by electrophoresis in 1% agarose gels in 50 mM potassium phosphate, pH 7.0 as described previously . Coat proteins were purified by methods described in detail elsewhere . These methods include chromatography in Sepharose CL-4B followed by pelleting of the virus from peak fractions by centrifugation at 25,000 rpm in the SW28 rotor overnight. Electrophoresis of purified virus-like particles was conducted in 1% agarose and 40 mM Tris-acetate, 2 mM EDTA, pH 8.0. Production of crude cell lysates, their separation into soluble and insoluble fractions, and their analysis by SDS gel electrophoresis have been also detailed in previous reports [10, 11].
Fluorescein labeling was conducted by reaction for 30 min. at room temperature in 20ul of 50 mM potassium phosphate pH7.0, 1 mM EDTA, 1 mM fluorescein-5-maleimide (from Helix, Inc.). Proteins were present at concentrations in the 0.5 to 2 mg/ml range. Reactions were terminated by the addition of DTT to a concentration of 50 mM. Unreacted controls were performed by adding DTT to the reaction before the protein. The products were subjected to electrophoresis in agarose gels under native conditions in 40 mM Tris-acetate, 2 mM EDTA, pH 8.0, and in SDS-polyacrylamide gels. Fluoresceinated products were detected by photography under UV illumination.
This work was supported by the Air Force Research Laboratory.
- Douglas T, Young M: Virus Particles as Templates for Materials Synthesis. Adv Mater. 1999, 11: 679-681. 10.1002/(SICI)1521-4095(199906)11:8<679::AID-ADMA679>3.0.CO;2-J.View ArticleGoogle Scholar
- Douglas T, Strable E, Willits D, Aitouchen A, Libera M, Young M: Protein Engineering of a Viral Cage for Constrained Nanomaterials Synthesis. Adv Mater. 2002, 14: 415-418. 10.1002/1521-4095(20020318)14:6<415::AID-ADMA415>3.0.CO;2-W.View ArticleGoogle Scholar
- Gillitzer E, Willits D, Young M, Douglas T: Chemical modification of a viral cage for multivalent presentation. Chem Comm. 2002, 2390-2391. 10.1039/b207853h.Google Scholar
- Douglas T, Young MJ: Host-guest encapsulation of materials by assembled virus protein cages. Nature. 1998, 393: 152-155. 10.1038/30211.View ArticleGoogle Scholar
- Wang Q, Kaltgrad E, Lin T, Johnson JE, Finn MG: Natural Supramolecular Building Blocks: Wild-Type Cowpea Mosaic Virus. Chemistry and Biology. 2002, 9: 805-811. 10.1016/S1074-5521(02)00165-5.View ArticleGoogle Scholar
- Wang Q, Lin T, Johnson JE, Finn MG: Natural Supramolecular Building Blocks: Cysteine-Added Mutants of Cowpea Mosaic Virus. Chemistry and Biology. 2002, 9: 813-819. 10.1016/S1074-5521(02)00166-7.View ArticleGoogle Scholar
- Wang Q, Lin T, Tang L, Johnson JE, Finn MG: Icosahedral Virus particles as Addressable Nanoscale Building Blocks. Angew Chem Int Ed. 2002, 41: 459-462. 10.1002/1521-3773(20020201)41:3<459::AID-ANIE459>3.3.CO;2-F.View ArticleGoogle Scholar
- Pickett G, Peabody DS: Encapsidation of Heterologous RNAs by Bacteriophage MS2 Coat Protein. Nucleic Acids Res. 1993, 21: 4621-4626.View ArticleGoogle Scholar
- Peabody DS: Translational Repression by Bacteriophage MS2 Coat Protein Expressed From a Plasmid: A System for Genetic Analysis of a Protein-RNA Interaction. J Biol Chem. 1990, 265: 5684-5689.Google Scholar
- Peabody DS, Al-Bitar L: Isolation of Viral Coat Protein Mutants With Altered Assembly and Aggregation Properties. Nucleic Acids Research. 2001, 29: e113-10.1093/nar/29.22.e113.View ArticleGoogle Scholar
- Peabody DS: The RNA-binding site of bacteriophage MS2 coat protein. EMBO J. 1993, 12: 595-600.Google Scholar
- Valegard K, Liljas L, Fridborg K, Unge T: The three-dimensional structure of the bacterial virus MS2. Nature. 1990, 345: 36-41. 10.1038/345036a0.View ArticleGoogle Scholar
- Golmohammadi R, Valegard K, Fridborg K, Liljas L: The refined structure of bacteriophage MS2 at 2.8A resolution. J Mol Bio. 1993, 234: 620-639. 10.1006/jmbi.1993.1616.View ArticleGoogle Scholar
- Golmohammadi R, Fridgorg K, Bundule M, Valegard K, Liljas L: The crystal structure of bacteriophage Qβ at 3.5A resolution. Structure. 1996, 4: 543-554.View ArticleGoogle Scholar
- Tars K, Fridborg K, Bundule M, Liljas L: The Three-Dimensional Structure of Bacteriophage PP7 from Pseudomonas aeruginosa at 3.7A Resolution. Virology. 2000, 272: 331-337. 10.1006/viro.2000.0373.View ArticleGoogle Scholar
- Liljas L, Fridborg K, Valegard K, Bundule M, Pumpens P: Crystal structure of bacteriophage fr capsids at 3.5A resolution. J Mol Biol. 1994, 244: 279-290. 10.1006/jmbi.1994.1729.View ArticleGoogle Scholar
- Ni C-Z, White CA, Mitchell RS, Wickersham J, Ramadurgam K, Peabody DS, Ely KR: Protein Science. 1996, 5: 2485-2493.View ArticleGoogle Scholar
- Tars K, Bundule M, Fridborg K, Liljas L: The Crystal Structure of Bacteriophage GA and a Comparison of Bacteriophages Belonging to the Major Groups of Escherichia coli Leviviruses. J Mol Biol. 1997, 271: 759-773. 10.1006/jmbi.1997.1214.View ArticleGoogle Scholar
- Studier FW, Rosenberg AH, Dunn JJ, Dubendorff JW: Use of T7 RNA polymerase to direct expression of cloned genes. Methods Enzymol. 1990, 185: 60-89.View ArticleGoogle Scholar
- Peabody DS, Lim F: Complementation of RNA binding site mutations in MS2 coat protein heterodimers. Nucleic Acids Res. 1996, 24: 2352-2359. 10.1093/nar/24.12.2352.View ArticleGoogle Scholar
- Peabody DS, Chakerian A: Asymmetric Contribution to RNA Binding by the Thr45 Residues of the MS2 Coat Protein Dimer. J Biol Chem. 1999, 274: 25403-25410. 10.1074/jbc.274.36.25403.View ArticleGoogle Scholar
- Powell AJ, Peabody DS: Asymmetric interactions in the adenosine-binding pockets of MS2 coat protein. BMC Molecular Biology. 2001, 2: 6-10.1186/1471-2199-2-6.View ArticleGoogle Scholar
- Peabody DS: Subunit Fusion Confers Tolerance to Peptide Insertions in a Virus Coat Protein. Arch Biochem Biophys. 1997, 347: 85-92. 10.1006/abbi.1997.0312.View ArticleGoogle Scholar
- Ellman GL: Tissue Sulfhydryl Groups. Arch Biochem Biophys. 1959, 82: 70-77.View ArticleGoogle Scholar
- Peabody DS, Ely KR, Edmundson AB: Obligatory hybridization of heterologous immunoglobulin light chains into covalently linked dimers. Biochemistry. 1980, 19: 2827-2834.View ArticleGoogle Scholar
- Berzin VM, Tsimanis AY, Gren EY, Aagorski W, Szafranski P: Effect of Chemical Modification of Cysteine Residues in the Phage MS2 Coat Protein on the Repressor Complex Formation With MS2 RNA. Bioorg Khim. 1981, 7: 894-899.Google Scholar
- Romaniuk P, Uhlenbeck OC: Nucleoside and Nucleotide Inactivation of R17 Coat Protein: Evidence for a Transient Covalent RNA-Protein bond. Biochemistry. 1985, 24: 4239-4244.View ArticleGoogle Scholar
- Higuchi R, Krummel B, Saiki RK: A general method of in vitro preparation and specific mutagenesis of DNA fragments. Nucleic Acids Res. 1988, 16: 7357-7367.View ArticleGoogle Scholar
- Ho SN, Hunt HD, Horton RM, Pullen JK, Pease LR: Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene. 1989, 77: 51-59. 10.1016/0378-1119(89)90358-2.View ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.